TriNetX will provide Regeneron secure, licensed access to de-identified health data from its global network of health system partners
The move opens Japan’s advanced life science market to Epigenica’s high-throughput epigenetic profiling kits
Under the agreement, healthcare professionals in the country will gain access to C2N’s PrecivityAD2 blood test
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
The product will target Type 2 diabetes management aligning with unmet needs in India’s expanding metabolic care landscape
The partnership initially will focus on cardiovascular and kidney diseases
ATEC secures exclusive U.S. commercial rights to Theradaptive’s OsteoAdapt osteoinductive bone graft, currently in clinical trials for spinal and dental applications
Valneva said regaining full rights to the vaccine will allow the company to “assume direct control over its supply chain and commercialization for endemic high-risk countries
For 2026 onwards, CPHI and PMEC India are evolving into two distinct, specialized shows
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
